Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?
Yıl: 2021 Cilt: 67 Sayı: 3 Sayfa Aralığı: 370 - 373 Metin Dili: İngilizce DOI: 10.5606/tftrd.2021.5248 İndeks Tarihi: 12-06-2022
Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?
Öz: Bisphosphonates are commonly used in the treatment of osteoporosis. Atypical femoral fracture (AFF) is a well-known adverse effect
of bisphosphonate use. The importance of genetic factors has been demonstrated in bone quality, bone turnover, and in the response to
osteoporosis treatment. Herein, we present two cases of bilateral AFFs after bisphosphonate use for a short period of time in members of the
same family (mother and her daughter) and discuss genetic predisposition to bisphosphonate-induced AFFs in the light of literature data.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
- 1. Saita Y, Ishijima M, Kaneko K. Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications. Ther Adv Chronic Dis 2015;6:185-93.
- 2. Tella SH, Gallagher JC. Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol 2014;142:155-70.
- 3. Lovy AJ, Koehler SM, Keswani A, Joseph D, Hasija R, Ghillani R. Atypical femur fracture during bisphosphonate drug holiday: a case series. Osteoporos Int 2015;26:1755-8.
- 4. Urano T, Inoue S. Recent genetic discoveries in osteoporosis, sarcopenia and obesity. Endocr J 2015;62:475-84.
- 5. Wang C, Zheng H, He JW, Zhang H, Yue H, Hu WW, et al. Genetic polymorphisms in the mevalonate pathway affect the therapeutic response to alendronate treatment in postmenopausal Chinese women with low bone mineral density. Pharmacogenomics J 2015;15:158-64.
- 6. López-Delgado L, Riancho-Zarrabeitia L, Riancho JA. Genetic and acquired factors influencing the effectiveness and toxicity of drug therapy in osteoporosis. Expert Opin Drug Metab Toxicol 2016;12:389-98.
- 7. Mashiba T, Turner CH, Hirano T, Forwood MR, Johnston CC, Burr DB. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 2001;28:524-31.
- 8. Alshahrani F, Kendler D. Femoral fractures in osteoporotic patients on bisphosphonates. A case report. J Clin Densitom 2012;15:380-4.
- 9. Wolin EA, Banks KP, Vroman PJ. Bisphosphonateassociated atypical subtrochanteric femur fracture. J Nucl Med Technol 2015;43:72-3.
- 10. Funck-Brentano T, Ostertag A, Debiais F, Fardellone P, Collet C, Mornet E, et al. Identification of a p.Arg708Gln variant in COL1A2 in atypical femoral fractures. Joint Bone Spine 2017;84:715-8.
- 11. Pérez-Núñez I, Pérez-Castrillón JL, Zarrabeitia MT, García-Ibarbia C, Martínez-Calvo L, Olmos JM, et al. Exon array analysis reveals genetic heterogeneity in atypical femoral fractures. A pilot study. Mol Cell Biochem 2015;409:45-50.
- 12. Nguyen HH, van de Laarschot DM, Verkerk AJMH, Milat F, Zillikens MC, Ebeling PR. Genetic Risk Factors for Atypical Femoral Fractures (AFFs): A Systematic Review. JBMR Plus 2018;2:1-11.
- 13. Bubbear JS. Atypical Femur Fractures in Patients Treated with Bisphosphonates: Identification, Management, and Prevention. Rambam Maimonides Med J 2016;7:e0032.
- 14. Oh CW, Oh JK, Park KC, Kim JW, Yoon YC. Prophylactic nailing of incomplete atypical femoral fractures. ScientificWorldJournal 2013;2013:450148.
| APA | okçu m, Koçak F, Kaya S, TUNCAY F (2021). Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?. , 370 - 373. 10.5606/tftrd.2021.5248 |
| Chicago | okçu mehmet,Koçak Fatmanur Aybala,Kaya Samet Sancar,TUNCAY FİGEN Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?. (2021): 370 - 373. 10.5606/tftrd.2021.5248 |
| MLA | okçu mehmet,Koçak Fatmanur Aybala,Kaya Samet Sancar,TUNCAY FİGEN Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?. , 2021, ss.370 - 373. 10.5606/tftrd.2021.5248 |
| AMA | okçu m,Koçak F,Kaya S,TUNCAY F Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?. . 2021; 370 - 373. 10.5606/tftrd.2021.5248 |
| Vancouver | okçu m,Koçak F,Kaya S,TUNCAY F Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?. . 2021; 370 - 373. 10.5606/tftrd.2021.5248 |
| IEEE | okçu m,Koçak F,Kaya S,TUNCAY F "Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?." , ss.370 - 373, 2021. 10.5606/tftrd.2021.5248 |
| ISNAD | okçu, mehmet vd. "Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?". (2021), 370-373. https://doi.org/10.5606/tftrd.2021.5248 |
| APA | okçu m, Koçak F, Kaya S, TUNCAY F (2021). Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?. Turkish Journal of Physical Medicine and Rehabilitation, 67(3), 370 - 373. 10.5606/tftrd.2021.5248 |
| Chicago | okçu mehmet,Koçak Fatmanur Aybala,Kaya Samet Sancar,TUNCAY FİGEN Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?. Turkish Journal of Physical Medicine and Rehabilitation 67, no.3 (2021): 370 - 373. 10.5606/tftrd.2021.5248 |
| MLA | okçu mehmet,Koçak Fatmanur Aybala,Kaya Samet Sancar,TUNCAY FİGEN Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?. Turkish Journal of Physical Medicine and Rehabilitation, vol.67, no.3, 2021, ss.370 - 373. 10.5606/tftrd.2021.5248 |
| AMA | okçu m,Koçak F,Kaya S,TUNCAY F Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?. Turkish Journal of Physical Medicine and Rehabilitation. 2021; 67(3): 370 - 373. 10.5606/tftrd.2021.5248 |
| Vancouver | okçu m,Koçak F,Kaya S,TUNCAY F Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?. Turkish Journal of Physical Medicine and Rehabilitation. 2021; 67(3): 370 - 373. 10.5606/tftrd.2021.5248 |
| IEEE | okçu m,Koçak F,Kaya S,TUNCAY F "Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?." Turkish Journal of Physical Medicine and Rehabilitation, 67, ss.370 - 373, 2021. 10.5606/tftrd.2021.5248 |
| ISNAD | okçu, mehmet vd. "Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?". Turkish Journal of Physical Medicine and Rehabilitation 67/3 (2021), 370-373. https://doi.org/10.5606/tftrd.2021.5248 |
